Trim Solution 3 (3-month package): Includes 12 solution doses, 12 vitamin skinny shots, and monthly IV infusions
Brain health and dementia risk: promising but evolving Large observational studies have associated GLP-1 use with a lower risk of Alzheimers disease compared to some other diabetes treatments (Xie et al., 2023)
In 2024, the plan opted to stop covering GLP-1 agonist medications (such as Ozempic and Mounjaro) for members who do not have diabetes
Research Community Feedback "Consistency is paramount in our cellular model testing
These peptides are highlighted for their ability to support muscle repair, reduce inflammation, and improve recovery times, making them valuable for athletic performance and therapeutic research
10.1038/s41467-023-39824-4 7 BainM